secwatch.observer — SEC 8-K summary
======================================

Issuer:     RESMED INC (RMD)
CIK:        0000943819
Form:       8-K
Filed at:   2024-08-01T23:59:59+00:00
Accession:  0001193125-24-191487
Event type: earnings
Sentiment:  positive
Materiality: 0.85
Item codes: 2.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ResMed Q4 revenue $1.22B (+9% YoY); EPS $1.98; dividend up 10% to $0.53
-----------------------------------------------------------------------

- Q4 FY2024 revenue $1,223.2M (+9% YoY, +10% constant currency); gross margin 58.5% (+350 bps).
- GAAP diluted EPS $1.98 (+27% YoY); non-GAAP diluted EPS $2.08 (+30% YoY).
- Operating cash flow $440M; debt repayments of $300M in Q4; FY2024 operating cash flow $1.4B.
- Quarterly dividend increased 10% to $0.53 per share (payable Sept 19, record Aug 15).
- Investor Day announced for September 30, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/943819/000119312524191487/0001193125-24-191487-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/943819/000119312524191487/d805836d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-191487

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer